Ari Shomair
Corporate Officer/Principal bij POINT Biopharma, Inc. (United States)
Actieve functies van Ari Shomair
| Bedrijven | Functie | Begin | Einde |
|---|---|---|---|
POINT Biopharma, Inc. (United States)
 POINT Biopharma, Inc. (United States) Miscellaneous Commercial ServicesCommercial Services Part of POINT Biopharma Global, Inc., POINT Biopharma, Inc. (United States) develops next-generation radioligand therapies for the treatment of cancer. The company is based in Indianapolis, IN. Joe McCann has been the CEO of the company since 2019. POINT Biopharma, Inc. (United States was acquired by Therapeutics Acquisition Corp. on June 30, 2021 for $578.95 million. | Corporate Officer/Principal | - | - |
Loopbaan van Ari Shomair
Eerdere bekende functies van Ari Shomair
| Bedrijven | Functie | Begin | Einde |
|---|---|---|---|
| POIT BIOP | Human Resources Officer | - | 27-12-2023 |
| Public Communications Contact | - | - |
Statistieken
Internationaal
| Verenigde Staten | 3 |
Operationeel
| Human Resources Officer | 1 |
| Public Communications Contact | 1 |
| Corporate Officer/Principal | 1 |
Sectoraal
| Health Technology | 2 |
| Commercial Services | 2 |
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Verwante bedrijven
| Beursgenoteerde bedrijven | 1 |
|---|---|
| POIT BIOP | Health Technology |
| Bedrijven in privébezit | 1 |
|---|---|
POINT Biopharma, Inc. (United States)
POINT Biopharma, Inc. (United States) Miscellaneous Commercial ServicesCommercial Services Part of POINT Biopharma Global, Inc., POINT Biopharma, Inc. (United States) develops next-generation radioligand therapies for the treatment of cancer. The company is based in Indianapolis, IN. Joe McCann has been the CEO of the company since 2019. POINT Biopharma, Inc. (United States was acquired by Therapeutics Acquisition Corp. on June 30, 2021 for $578.95 million. | Commercial Services |
- Beurs
- Insiders
- Ari Shomair
- Ervaring